Literature DB >> 21262264

Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes.

Pravinkumar Bhutada1, Yogita Mundhada, Kuldeep Bansod, Santosh Tawari, Shaktipal Patil, Pankaj Dixit, Sudhir Umathe, Dharmendra Mundhada.   

Abstract

Memory impairment induced by streptozotocin in rats is a consequence of changes in CNS that are secondary to chronic hyperglycemia, impaired oxidative stress, cholinergic dysfunction, and changes in glucagon-like peptide (GLP). Treatment with antihyperglycemics, antioxidants, and cholinergic agonists are reported to produce beneficial effect in this model. Berberine, an isoquinoline alkaloid is reported to exhibit anti-diabetic and antioxidant effect, acetylcholinesterase (AChE) inhibitor, and increases GLP release. However, no report is available on influence of berberine on streptozotocin-induced memory impairment. Therefore, we tested its influence against cognitive dysfunction in streptozotocin-induced diabetic rats using Morris water maze paradigm. Lipid peroxidation and glutathione levels as parameters of oxidative stress and choline esterase (ChE) activity as marker of cholinergic function were assessed in the cerebral cortex and hippocampus. Thirty days after diabetes induction rats showed a severe deficit in learning and memory associated with increased lipid peroxidation, decreased reduced glutathione, and elevated ChE activity. In contrast, chronic treatment with berberine (25-100mg/kg, p.o., twice daily, 30 days) improved cognitive performance, lowered hyperglycemia, oxidative stress, and ChE activity in diabetic rats. In another set of experiment, berberine (100mg/kg) treatment during training trials also improved learning and memory, lowered hyperglycemia, oxidative stress, and ChE activity. Chronic treatment (30 days) with vitamin C or metformin, and donepezil during training trials also improved diabetes-induced memory impairment and reduced oxidative stress and/or choline esterase activity. In conclusion, the present study demonstrates treatment with berberine prevents the changes in oxidative stress and ChE activity, and consequently memory impairment in diabetic rats.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21262264     DOI: 10.1016/j.bbr.2011.01.022

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  51 in total

1.  Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography.

Authors:  Peifeng Dai; Junhua Wang; Lin Lin; Yanyan Zhang; Zhengping Wang
Journal:  Exp Ther Med       Date:  2015-06-22       Impact factor: 2.447

Review 2.  Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

Authors:  Efrat Kravitz; James Schmeidler; Michal Schnaider Beeri
Journal:  Endocrinol Metab Clin North Am       Date:  2013-09       Impact factor: 4.741

Review 3.  Neural circuitry and immunity.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

4.  Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats.

Authors:  Hamid Kalalian Moghaddam; Tourandokht Baluchnejadmojarad; Mehrdad Roghani; Mehdi Khaksari; Pirasteh Norouzi; Malihea Ahooie; Fatemeh Mahboobi
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

5.  Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats.

Authors:  Shruti Pandey; Debapriya Garabadu
Journal:  Cell Mol Neurobiol       Date:  2016-09-01       Impact factor: 5.046

6.  Neuroprotective effects of Nigella sativa extract upon the hippocampus in PTU-induced hypothyroidism juvenile rats: A stereological study.

Authors:  Farimah Asiaei; Alireza Fazel; Ali Akbar Rajabzadeh; Mahmoud Hosseini; Farimah Beheshti; Masoumeh Seghatoleslam
Journal:  Metab Brain Dis       Date:  2017-05-11       Impact factor: 3.584

7.  Activation of mTOR signaling mediates the increased expression of AChE in high glucose condition: in vitro and in vivo evidences.

Authors:  Yao-Wu Liu; Liang Zhang; Yu Li; Ya-Qin Cheng; Xia Zhu; Fan Zhang; Xiao-Xing Yin
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

8.  Effects of Deltamethrin on striatum and hippocampus mitochondrial integrity and the protective role of Quercetin in rats.

Authors:  Salim Gasmi; Rachid Rouabhi; Mohamed Kebieche; Samira Boussekine; Aya Salmi; Nadjiba Toualbia; Chahinez Taib; Zina Bouteraa; Hajer Chenikher; Sara Henine; Belgacem Djabri
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-27       Impact factor: 4.223

9.  Berberine ameliorates rats model of combined Alzheimer's disease and type 2 diabetes mellitus via the suppression of endoplasmic reticulum stress.

Authors:  Wei-Ting Xuan; Han Wang; Peng Zhou; Ting Ye; Hua-Wu Gao; Shu Ye; Jing-Hui Wang; Meng-Lian Chen; Hang Song; Yan Wang; Biao Cai
Journal:  3 Biotech       Date:  2020-07-29       Impact factor: 2.406

10.  Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction.

Authors:  Anil Kumar; Jitendriya Mishra; Kanwaljit Chopra; Dinesh K Dhull
Journal:  Psychopharmacology (Berl)       Date:  2015-10-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.